The gut microbiota (GM) is related to obesity and other metabolic diseases. To detect GM markers for obesity in patients with different metabolic abnormalities and investigate their relationships with clinical indicators, 1,914 Chinese adults were enrolled for 16S rRNA gene sequencing in this retrospective study. Based on GM composition, Random forest classifiers were constructed to screen the obesity patients with (Group OA) or without metabolic diseases (Group O) from healthy individuals (Group H), and high accuracies were observed for the discrimination of Group O and Group OA (areas under the receiver operating curve (AUC) equal to 0.68 and 0.76, respectively). Furthermore, six GM markers were shared by obesity patients with various metabolic disorders (Bacteroides, Parabacteroides, Blautia, Alistipes, Romboutsia and Roseburia). As for the discrimination with Group O, Group OA exhibited low accuracy (AUC= 0.57). Nonetheless, GM classifications to distinguish between Group O and the obese patients with specific metabolic abnormalities were not accurate (AUC values from 0.59 to 0.66). Common biomarkers were identified for the obesity patients with high uric acid, high serum lipids and high blood pressure, such as Clostridium XIVa, Bacteroides and Roseburia. A total of 20 genera were associated with multiple significant clinical indicators. For example, Blautia, Romboutsia, Ruminococcus2, Clostridium sensu stricto and Dorea were positively correlated with indicators of bodyweight (including waistline and body mass index) and serum lipids (including low density lipoprotein, triglyceride and total cholesterol). In contrast, the aforementioned clinical indicators were negatively associated with Bacteroides, Roseburia, Butyricicoccus, Alistipes, Parasutterella, Parabacteroides and Clostridium IV. Generally, these biomarkers hold the potential to predict obesity-related metabolic abnormalities, and interventions based on these biomarkers might be beneficial to weight loss and metabolic risk improvement.
[1]Peoples Liberat Army Gen Hosp, Hlth Management Inst, Beijing, Peoples R China.
[2]Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Wuhan, Hubei, Peoples R China.
[3]WeHealthGene Inst, Dept Microbial Res, Shenzhen, Guangdong, Peoples R China.
[4]Shenzhen Childrens Hosp, Joint Lab Microecol & Childrens Hlth, Shenzhen, Guangdong, Peoples R China.
[5]Shenzhen WeHealthGene Co Ltd, Shenzhen, Guangdong, Peoples R China.
[6]Natl Res Inst Hlth, Beijing, Peoples R China.
[7]City Univ Hong Kong, Coll Sci & Engn, Dept Comp Sci, Hong Kong, Peoples R China.
[8]Nankai Univ, Sch Stat & Data Sci, Tianjin, Peoples R China.
[9]Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China.
[10]910th Hosp Peoples Liberat Army, Hlth Management Ctr, Quanzhou, Fujian, Peoples R China.
[11]Jilin Univ, China Japan Union Hosp, Changchun, Jilin, Peoples R China.
[12]Shenzhen Childrens Hosp, Dept Resp, Shenzhen, Guangdong, Peoples R China.
[13]Longkou Peoples Hosp, Dept Cardiol, Longkou, Shandong, Peoples R China.
[14]Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada.
[15]Henan Prov Peoples Hosp, Dept Hlth Management, Zhengzhou, Henan, Peoples R China.
(8.0+极速模式)